FR3016520A3 - NUTRITIONAL COMPOSITION BASED ON HYALURONIC ACID FOR THE NUTRITION OF JOINTS - Google Patents
NUTRITIONAL COMPOSITION BASED ON HYALURONIC ACID FOR THE NUTRITION OF JOINTS Download PDFInfo
- Publication number
- FR3016520A3 FR3016520A3 FR1550479A FR1550479A FR3016520A3 FR 3016520 A3 FR3016520 A3 FR 3016520A3 FR 1550479 A FR1550479 A FR 1550479A FR 1550479 A FR1550479 A FR 1550479A FR 3016520 A3 FR3016520 A3 FR 3016520A3
- Authority
- FR
- France
- Prior art keywords
- composition
- composition according
- per
- content
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 69
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 40
- 229920002674 hyaluronan Polymers 0.000 title claims abstract description 14
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims abstract description 7
- 229960003160 hyaluronic acid Drugs 0.000 title claims abstract description 7
- 230000035764 nutrition Effects 0.000 title description 12
- 108010010803 Gelatin Proteins 0.000 claims abstract description 30
- 229920000159 gelatin Polymers 0.000 claims abstract description 30
- 235000019322 gelatine Nutrition 0.000 claims abstract description 30
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 30
- 239000008273 gelatin Substances 0.000 claims abstract description 29
- 239000000499 gel Substances 0.000 claims abstract description 11
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 36
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 14
- 241001465754 Metazoa Species 0.000 claims description 11
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 11
- HHVIBTZHLRERCL-UHFFFAOYSA-N methylsulphonylmethane Natural products CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 claims description 11
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 11
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 11
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 10
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 10
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 9
- 241000283086 Equidae Species 0.000 claims description 9
- 239000007979 citrate buffer Substances 0.000 claims description 9
- 235000015872 dietary supplement Nutrition 0.000 claims description 9
- 229940016409 methylsulfonylmethane Drugs 0.000 claims description 9
- 235000015277 pork Nutrition 0.000 claims description 9
- 235000010241 potassium sorbate Nutrition 0.000 claims description 9
- 239000004302 potassium sorbate Substances 0.000 claims description 9
- 229940069338 potassium sorbate Drugs 0.000 claims description 9
- CVCQAQVBOPNTFI-AAONGDSNSA-N (3r,4r,5s,6r)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol;sulfuric acid Chemical compound OS(O)(=O)=O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O CVCQAQVBOPNTFI-AAONGDSNSA-N 0.000 claims description 7
- 241000282472 Canis lupus familiaris Species 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims description 7
- 229940099552 hyaluronan Drugs 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- 150000007524 organic acids Chemical class 0.000 claims description 6
- 239000006188 syrup Substances 0.000 claims description 6
- 235000020357 syrup Nutrition 0.000 claims description 6
- 239000013543 active substance Substances 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 241001493546 Suina Species 0.000 claims description 3
- -1 parabens Chemical class 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 claims description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical class OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 2
- 239000008351 acetate buffer Substances 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- 235000003599 food sweetener Nutrition 0.000 claims description 2
- 229960001911 glucosamine hydrochloride Drugs 0.000 claims description 2
- 229960004903 invert sugar Drugs 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 2
- 150000002823 nitrates Chemical class 0.000 claims description 2
- 150000002826 nitrites Chemical class 0.000 claims description 2
- 235000005985 organic acids Nutrition 0.000 claims description 2
- 239000004014 plasticizer Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 235000013772 propylene glycol Nutrition 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 239000003765 sweetening agent Substances 0.000 claims description 2
- 239000000047 product Substances 0.000 description 16
- 150000001413 amino acids Chemical class 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 241000282412 Homo Species 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 235000005805 Prunus cerasus Nutrition 0.000 description 2
- 235000009226 Prunus puddum Nutrition 0.000 description 2
- 244000207449 Prunus puddum Species 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007938 effervescent tablet Substances 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- MTDHILKWIRSIHB-UHFFFAOYSA-N (5-azaniumyl-3,4,6-trihydroxyoxan-2-yl)methyl sulfate Chemical compound NC1C(O)OC(COS(O)(=O)=O)C(O)C1O MTDHILKWIRSIHB-UHFFFAOYSA-N 0.000 description 1
- 241000751068 Allotropa virgata Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003848 cartilage regeneration Effects 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 230000036570 collagen biosynthesis Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002849 glucosamine sulfate Drugs 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- WJRZEJVEUPQUPJ-DYQIYBMZSA-M potassium;(2e,4e)-hexa-2,4-dienoate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [K+].C\C=C\C=C\C([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O WJRZEJVEUPQUPJ-DYQIYBMZSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
- A23L29/284—Gelatin; Collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Nutrition Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Mycology (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Fodder In General (AREA)
- Medicinal Preparation (AREA)
Abstract
La présente invention porte sur une composition nutritionnelle, sous forme de gel solidifié, comprenant de la gélatine et un sel pharmaceutiquement acceptable de l'acide hyaluronique.The present invention relates to a nutritional composition, in the form of a solidified gel, comprising gelatin and a pharmaceutically acceptable salt of hyaluronic acid.
Description
Composition nutritionnelle à base d'acide hyaluronique pour la nutrition des articulations Domaine de l'Invention L'invention se rapporte à une composition nutritionnelle à base d'hyaluronate de sodium destinée pour la nutrition des articulations. Il s'agit d'un complément alimentaire sous forme de gel solidifié.FIELD OF THE INVENTION The invention relates to a nutritional composition based on sodium hyaluronate intended for the nutrition of the joints. It is a food supplement in the form of solidified gel.
Arrière-Plan de l'Invention Les Gélatines et hydrolysats sous forme de gel sont une riche source d'acides aminés nécessaires pour construction du tissu conjonctif. La gélatine est une riche source d'acides aminés nécessaires pour la biosynthèse du collagène. Elle contient 18 acides aminés, dont neuf acides aminés essentiels. Les principales acides aminés de collagène sont représentés par la glycine (33,5%), la proline (12%) et l'hydroxyproline (10 %) (Jelfnek et al. (2002)). Les gélatines et leurs hydrolysats sont donc utilisés pour les suppléments nutritionnels des humains et des animaux afin d'améliorer notamment l'état des articulations, des tendons et de la peau. Les substances qui sont principalement utilisées comme composants de suppléments nutritionnels pour soutenir la régénération du tissu conjonctif, sont en outre l'hyaluronane, la chondroïtine, la glucosamine, éventuellement le méthylsulfonylméthane, les oligo-éléments et les vitamines. Ces substances actives sont présentes en tant que compléments nutritionnels dans diverses combinaisons et doses. Il ya un certain nombre de documents qui décrivent les effets de ces substances après l'administration orale (Bucci et Turpin, 2004; Balogh et al., 2008 ; Stanêfkovà et al., 2004 ; Meulyzer et al. , 2008 ; Oke et McIlwraith, 2010 ; Conte et al., 1995 ; Hanson et al., 1997). Il ya aussi des études qui confirment l'effet de l'administration orale de la gélatine sur l'homéostasie des acides aminés qui sont importants pour la régénération de cartilages chez les chevaux montrant que les acides aminés à partir de gélatine sont absorbés chez les chevaux rapidement et deviennent disponibles pour le métabolisme des acides aminés (Coenen et al. (2006)). Trentham et al. (1993), Oessere et al. (1999), et Nomura al. (2005) ont confirmé l'effet positif de la gélatine sur la régénération du cartilage chez des animaux de laboratoire et chez l'homme après l'administration orale. Des compléments nutritionnels ainsi produits jusqu'ici visant à soutenir la nutrition des articulations sont le plus souvent disponibles sous forme de solutions, de sirops, de capsules de gélatine, des comprimés, des poudres et des comprimés effervescents destinés à préparation de boissons.BACKGROUND OF THE INVENTION Gelatin and gel-form hydrolysates are a rich source of amino acids needed for construction of connective tissue. Gelatin is a rich source of amino acids needed for collagen biosynthesis. It contains 18 amino acids, including nine essential amino acids. The main amino acids of collagen are glycine (33.5%), proline (12%) and hydroxyproline (10%) (Jelfnek et al (2002)). Gelatins and their hydrolysates are therefore used for the nutritional supplements of humans and animals to improve the condition of the joints, tendons and skin. The substances which are mainly used as components of nutritional supplements to support the regeneration of the connective tissue are, in addition, hyaluronan, chondroitin, glucosamine, possibly methylsulfonylmethane, trace elements and vitamins. These active substances are present as nutritional supplements in various combinations and doses. There are a number of documents that describe the effects of these substances after oral administration (Bucci and Turpin 2004, Balogh et al., 2008, Stanêfkovà et al., 2004, Meulyzer et al., 2008, Oke and McIlwraith Conte et al., 1995, Hanson et al., 1997). There are also studies that confirm the effect of oral administration of gelatin on homeostasis of amino acids that are important for the regeneration of cartilage in horses showing that amino acids from gelatin are absorbed in horses rapidly and become available for amino acid metabolism (Coenen et al (2006)). Trentham et al. (1993), Oessere et al. (1999), and Nomura al. (2005) confirmed the positive effect of gelatin on cartilage regeneration in laboratory animals and in humans after oral administration. Nutritional supplements so far produced to support joint nutrition are most often available as solutions, syrups, gelatin capsules, tablets, powders and effervescent tablets for the preparation of beverages.
Ces produits humains et vétérinaires disponibles et utilisés normalement sur le marché présentent des exigences généralement élevées pour le stockage, la distribution, ou exigent l'addition d'eau et le mélange ultérieur, ce qui est particulièrement peu pratique lorsqu'ils sont utilisés chez les animaux, par exemple dans le milieu des étables. Les compléments nutritionnels pour la nutrition des articulations sous la forme de boissons aromatisées contenant lesdites substances actives mentionnées en dessus pour régénérer le cartilage sont traitées, par exemple, dans les documents EP 1263418 et US 6391864. Un inconvénient de cette forme du produit est en particulier la nécessité de mesurer par un jaugeur la quantité recommandée par le fabricant et une préparation longue de la dose. Le document US 6391864 mentionne, outre les accessoires sous la forme de boissons même les accessoires sous la forme de bâtonnets sucrés. L'inconvénient des produits mentionnés dans les documents ci-dessus est qu'ils ne contiennent pas de gélatine en tant que source d'acides aminés pour la biosynthèse du collagène. Les suppléments nutritionnels peuvent aussi prendre la forme des comprimés effervescents qui sont abordés par exemple dans le document US 6956029. Un tel produit peut présenter un inconvénient résultant de la nécessité d'ajouter de l'eau pour former une boisson et, dans le cas d'alimentation des animaux, également que cela pourrait conduire à la réception incomplète de la dose quotidienne recommandée. Le document US 6924273 se rapporte à compléments sous forme de gels ou pâtes. Ces produits contiennent, outre les substances actives mentionnées ci-dessus, les adjuvants qui sont conçus pour épaissir le produit. Dans ces produits sont contenues des substances de la série de celluloses modifiées, utilisées pour épaissir le produit et qui n'ont aucune importance pour la nutrition des articulations. Dans le document US 6607745 est traité un produit pour la nutrition des articulations conçu et destiné à la consommation humaine, l'alimentation des chiens, des chats et des chevaux sous la forme de capsules contenant uniquement de l'acide hyaluronique ou ses sels en une quantité de 0,1 p.g à 400 p.g / kg de poids vif. L'acide hyaluronique peut être, selon ce document, également ajouté à la nourriture ou à l'eau. L'inconvénient de ce produit est qu'il ne comprend pas de ressources des acides aminés qui sont requis pour la nutrition des articulations. Le document DE 10217808 Al décrit un produit pour la nutrition des articulations chez les humains et les animaux, qui ne contient parmi les ingrédients actifs mentionnés ci-dessus que d'hydrolysat de la gélatine en combinaison avec la vitamine E et C. Ce produit peut être présenté sous la forme de comprimés, de boissons, ou de capsules de gélatine. L'inconvénient de ce produit est qu'il ne contient pas d'hyaluronane. Objet de l'Invention Lesdits désavantages et inconvénients sont éliminés par une composition nutritionnelle qui est caractérisée en ce qu'elle comprend de la gélatine et un sel phannaceutiquement acceptable de l'acide hyaluronique, de préférence l'hyaluronate de sodium ou l'hyaluronate de potassium, tout en étant sous forme de gel solidifié. La teneur en gélatine, au moins 180 Bloom, de préférence 180 à 250 Bloom, dans la composition nutritionnelle selon l'invention est dans la plage de 70 à 400 g, de préférence de 112 à 250 g pour 1 kg de la composition, et la teneur en hyaluronate de sodium dans la plage de 0,001 à 15 g, de préférence de 4 à 5 g pour 1 kg de la composition. Bloom est un indicateur de résistance du gel de gélatine produit. Selon l'invention préférée, la composition nutritionnelle comprend en outre l'hydrolysat de gélatine, dont la teneur dans la composition est dans la plage de 0,001 à 400 g, de préférence 40 à 100 g pour 1 kg de la composition. Selon une variante de l'invention il est avantageux que la composition nutritionnelle comprend un tampon sur la base des acides organiques, de préférence choisi dans le groupe comprenant un tampon au citrate, un tampon d'acétate, conjointement avec un conservateur, de préférence choisi dans le groupe comprenant l'acide sorbique et ses sels, l'acide benzoïque et ses sels, les parabens, les sulfites, les nitrates ou nitrites. Le contenu du tampon de 10 à 100 mM à base d'acides organiques avec pH de 3 à 8 est dans la plage de 0,001 à 700 g, de préférence de 400 à 600 g pour 1 kg de la composition, et la teneur en agent de conservation est dans l'intervalle de 0,001 à 50 g, de préférence de 5 à 20 g pour 1 kg de la composition. Selon une autre variante de réalisation préférée de l'objet de l'invention, la composition nutritionnelle comprend encore au moins une substance active, appelée chondroprotecteur, choisie dans le groupe comprenant le sulfate de chondroïtine, le sulfate de glucosamine, le chlorhydrate de glucosamine, methylsulfonylméthane. La teneur en sulfate de chondroïtine est de préférence dans la plage de 0,001 à 100 g, de préférence de 10 à 40 g pour 1 kg de la composition. La teneur en sulfate de glucosamine est de préférence dans la plage de 0,001 à 100 g, de préférence de 10 à 30 g pour 1 kg de la composition. La teneur en méthylsulfonylméthane est de préférence dans la plage de 0,001 à 100 g, avantageusement de 10 à 30 g pour 1 kg de la composition.These human and veterinary products available and normally used on the market have generally high requirements for storage, distribution, or require the addition of water and the subsequent mixing, which is particularly impractical when used at home. animals, for example in the middle of the stables. Nutritional supplements for the nutrition of joints in the form of flavored drinks containing said active substances mentioned above to regenerate cartilage are treated, for example, in EP 1263418 and US 6391864. A disadvantage of this form of the product is in particular the need to measure by a measurer the amount recommended by the manufacturer and a long preparation of the dose. Document US 6391864 mentions, in addition to the accessories in the form of beverages, even the accessories in the form of sugar sticks. The disadvantage of the products mentioned in the above documents is that they do not contain gelatin as a source of amino acids for the biosynthesis of collagen. Nutritional supplements may also take the form of effervescent tablets which are discussed for example in US 6956029. Such a product may present a drawback resulting from the need to add water to form a drink and, in the case of also may lead to incomplete reception of the recommended daily dose. US 6924273 relates to supplements in the form of gels or pastes. These products contain, in addition to the active substances mentioned above, adjuvants which are designed to thicken the product. In these products are contained substances of the series of modified celluloses used to thicken the product and which have no importance for the nutrition of the joints. In US 6607745 is treated a product for the nutrition of joints designed and intended for human consumption, feeding dogs, cats and horses in the form of capsules containing only hyaluronic acid or its salts in one amount of 0.1 μg to 400 μg / kg body weight. Hyaluronic acid can be, according to this document, also added to food or water. The disadvantage of this product is that it does not include amino acid resources that are required for joint nutrition. DE 10217808 A1 discloses a product for the nutrition of joints in humans and animals, which contains among the above-mentioned active ingredients only hydrolyzate of gelatin in combination with vitamin E and C. This product can be presented in the form of tablets, drinks, or gelatin capsules. The disadvantage of this product is that it does not contain hyaluronan. OBJECT OF THE INVENTION Said disadvantages and disadvantages are eliminated by a nutritional composition which is characterized in that it comprises gelatin and a pharmaceutically acceptable salt of hyaluronic acid, preferably sodium hyaluronate or hyaluronate. potassium, while being in the form of solidified gel. The gelatin content, at least 180 Bloom, preferably 180 to 250 Bloom, in the nutritional composition according to the invention is in the range from 70 to 400 g, preferably from 112 to 250 g per 1 kg of the composition, and the sodium hyaluronate content in the range of 0.001 to 15 g, preferably 4 to 5 g per 1 kg of the composition. Bloom is an indicator of resistance of gelatin gel produced. According to the preferred invention, the nutritional composition further comprises the gelatin hydrolyzate, the content of which in the composition is in the range of 0.001 to 400 g, preferably 40 to 100 g per 1 kg of the composition. According to one variant of the invention, it is advantageous that the nutritional composition comprises a buffer based on organic acids, preferably chosen from the group comprising a citrate buffer, an acetate buffer, together with a preservative, preferably chosen in the group comprising sorbic acid and its salts, benzoic acid and its salts, parabens, sulphites, nitrates or nitrites. The content of the 10 to 100 mM organic acid buffer with pH of 3 to 8 is in the range of 0.001 to 700 g, preferably 400 to 600 g per 1 kg of the composition, and the content of agent in the range of 0.001 to 50 g, preferably 5 to 20 g per 1 kg of the composition. According to another preferred embodiment of the subject of the invention, the nutritional composition also comprises at least one active substance, called chondroprotecteur, chosen from the group comprising chondroitin sulfate, glucosamine sulphate, glucosamine hydrochloride, methylsulfonylmethane. The chondroitin sulfate content is preferably in the range of 0.001 to 100 g, preferably 10 to 40 g per 1 kg of the composition. The glucosamine sulphate content is preferably in the range of 0.001 to 100 g, preferably 10 to 30 g per 1 kg of the composition. The methylsulfonylmethane content is preferably in the range of 0.001 to 100 g, preferably 10 to 30 g per 1 kg of the composition.
En plus, la composition nutritionnelle selon la présente invention peut comprendre un plastifiant, de préférence choisi dans le groupe comprenant le glycérol, le sorbitol, le 1,2- propanediol. En plus, la composition nutritionnelle selon l'invention peut comprendre une matière sucrante, de préférence choisi dans le groupe comprenant les édulcorants, le saccharose, le sucre de glucose ou le sucre inverti. La composition nutritionnelle selon l'invention est utilisée comme un complément nutritionnel pour humains et / ou animaux, de préférence bêtes, artiodactyles ou périssodactyles, de préférence pour chiens ou chevaux. L'avantage de la composition nutritionnelle sous forme en gel solidifié est qu'elle comprend les composants constructeurs les plus importants de tissu conjonctif. Une telle forme de l'application n'exige plus aucune préparation ou traitement et est directement préparée à la consommation. D'autres avantages de la composition nutritionnelle selon l'invention sont une grande stabilité, une facilité de manipulation, et en plus, elle est attrayante pour les animaux (voir Fig. 1 et 2), ce qui suggère la possibilité d'utiliser la composition à la fois comme une récompense pour l'animal ou pour l'établissement et le maintien de contacts sociaux entre l'homme et l'animal. Selon un mode de réalisation, la composition nutritionnelle peut contenir 130,448 g de gélatine de porc, 400 g de 50 mM de tampon au citrate, 292,5 g de saccharose, 140 g de sirop de glucose, 8 g de sorbate de potassium, 4 g de glycérol, 4 g de hyaluronate de sodium, 19 g de sulfate de chondroïtine et en outre 2 g d'aromatisant et 0,052 g de colorant pour 1 kg de la composition. Selon un mode de réalisation, la composition nutritionnelle peut contenir 250 g de élatine de s orc 67 d'h drol sat de élatine 600 de 50 mM de tam on au citrate 12 de sorbate de potassium, 4 g de glycérol, 5 g d'hyaluronane de sodium, 20 g de sulfate de chondroïtine, 20 g de sulfate de glucosamine, 20 g de méthylsulfonylméthane et en plus 2 g d'aromatisant pour 1 kg de la composition. La teneur optimale des composants de la composition nutritionnelle à utiliser dans la nutrition des articulations chez les chevaux selon la présente invention à 1 kg de la composition est comme suit : 130,448 g de gélatine de porc (au moins 200 Bloom), 400 g de 50 mM de tampon au citrate, 292,5 g de saccharose sous forme cristalline, 140 g de sirop de glucose 43 DE, 8 g de sorbate de potassium, 4 g de glycérol, 4 g de hyaluronate de sodium (Nutrihyl®), 19 g de sulfate de chondroïtine, 2 g d'aromatisant et 0,052 g de colorant. La teneur optimale des composants de la composition nutritionnelle à utiliser dans la nutrition des articulations chez les chiens selon la présente invention à 1 kg de la composition est comme suit : 250 g de gélatine de porc (au moins 200 Bloom), 67 g d'hydrolysat de gélatine, 600 g de 50 mM de tampon au citrate, 12 g de sorbate de potassium, 4 g de glycérol, 5 g d'hyaluronate de sodium (Nutrihyl®), 20 g de sulfate de chondroïtine, 20 g de sulfate de glucosamine, 20 g de méthylsulfonylméthane et 2 g d'aromatisant. La préparation des compositions nutritionnelles selon la présente invention consiste à dissoudre tous leurs composants en produisant progressivement un mélange à consistance unifiée. A chaud, le gel est versé dans des moules et après la solidification, le produit est emballé dans un paquet. Pendant le stockage du gel solidifié, il est important d'observer les conditions de stockage dont la plus importante est de maintenir le produit à une température de 4 à 25 °C et dans un sachet clos. En suivant ces consignes, le consommateur évite le déséchage du produit ou la modification éventuelle de sa consistance. La composition nutritionnelle selon l'invention permet une l'administration a long terme, en particulier aux individus avec le tissu conjonctif endommagé. La composition préparée selon l'exemple 1 ci-dessous peut être administrée non seulement aux chevaux, mais aussi à d'autres périssodactyles et artiodactyla. La composition préparée selon l'exemple 2 ci- des sous peut être administrée outre les chiens à d'autres bêtes. Les exemples suivants de réalisation de la composition nutritionnelle selon l'invention servent uniquement à l'illustrer, sans la limiter en aucune façon.In addition, the nutritional composition according to the present invention may comprise a plasticizer, preferably selected from the group consisting of glycerol, sorbitol, 1,2-propanediol. In addition, the nutritional composition according to the invention may comprise a sweetening material, preferably selected from the group consisting of sweeteners, sucrose, glucose sugar or invert sugar. The nutritional composition according to the invention is used as a nutritional supplement for humans and / or animals, preferably beasts, artiodactyls or perissodactyls, preferably for dogs or horses. The advantage of the solidified gel form nutritional composition is that it comprises the most important building components of connective tissue. Such form of application no longer requires any preparation or treatment and is directly prepared for consumption. Other advantages of the nutritional composition according to the invention are high stability, ease of handling, and in addition, it is attractive to animals (see Figs 1 and 2), suggesting the possibility of using the composition both as a reward for the animal or for establishing and maintaining social contacts between man and animal. According to one embodiment, the nutritional composition may contain 130.448 g of pork gelatin, 400 g of 50 mM citrate buffer, 292.5 g of sucrose, 140 g of glucose syrup, 8 g of potassium sorbate, 4 g glycerol, 4 g of sodium hyaluronate, 19 g of chondroitin sulfate and further 2 g of flavoring and 0.052 g of dye per 1 kg of the composition. According to one embodiment, the nutritional composition may contain 250 g of elastin 600 elastin elastin 600 of 50 mM of potassium sorbate citrate 12 buffer, 4 g of glycerol, 5 g of sodium hyaluronan, 20 g of chondroitin sulfate, 20 g of glucosamine sulphate, 20 g of methylsulfonylmethane and in addition 2 g of flavoring per 1 kg of the composition. The optimum content of the components of the nutritional composition to be used in the nutrition of the joints in horses according to the present invention to 1 kg of the composition is as follows: 130.448 g of pork gelatin (at least 200 Bloom), 400 g of 50 mM citrate buffer, 292.5 g crystalline sucrose, 140 g 43 DE glucose syrup, 8 g potassium sorbate, 4 g glycerol, 4 g sodium hyaluronate (Nutrihyl®), 19 g of chondroitin sulfate, 2 g of flavoring and 0.052 g of dye. The optimum content of the components of the nutritional composition for use in the nutrition of joints in dogs according to the present invention to 1 kg of the composition is as follows: 250 g of pork gelatin (at least 200 Bloom), 67 g of gelatin hydrolyzate, 600 g of 50 mM citrate buffer, 12 g of potassium sorbate, 4 g of glycerol, 5 g of sodium hyaluronate (Nutrihyl®), 20 g of chondroitin sulfate, 20 g of sodium sulfate, glucosamine, 20 g of methylsulfonylmethane and 2 g of flavoring. The preparation of the nutritional compositions according to the present invention consists in dissolving all their components by progressively producing a mixture with a unified consistency. When warm, the gel is poured into molds and after solidification, the product is packaged in a package. During the storage of the solidified gel, it is important to observe the storage conditions, the most important of which is to maintain the product at a temperature of 4 to 25 ° C and in a closed bag. By following these instructions, the consumer avoids the desiccation of the product or the possible modification of its consistency. The nutritional composition of the invention allows long-term administration, particularly to individuals with damaged connective tissue. The composition prepared according to Example 1 below can be administered not only to horses, but also to other perissodactyls and artiodactyla. The composition prepared according to Example 2 below can be administered in addition to dogs to other animals. The following examples of embodiment of the nutritional composition according to the invention serve only to illustrate it, without limiting it in any way.
Brève Description des Dessins Fig. 1 : Résultats du test de palatabilité du gel solidifié sucré chez les chevaux (n=109) Fig. 2 : Résultats du test de palatabilité du gel solidifié non sucré chez les chiens de races différentes (n=25) Exemples de l'Invention Exemple 1 L'exemple illustre la composition optimale de 1 kg de la composition nutritionnelle selon l'invention pour la nutrition des articulations chez les chevaux. Les composants en question sont pesés et dissous pour être progressivement mélangés. La composition de gélatine préparée sous forme de solution est ensuite versée dans des moules pour la laisser se solidifier, ensuite elle est découpée et emballée dans des sacs avec fermeture à glissière. Composant Quantité (g/kg) Gélatine de porc (min. 200 Bloom) 130,448 Tampon au citrate, molarité 50 mM ; pH 5,8 400 Saccharose 292,5 Sirop de glucose 43 DE 140 Sorbate de potassium 8 Glycérol 4 Hyaluronate de sodium (Nutrihyl®) 4 Sulfate de chondroïtine 19 Aromatisant (griotte) 2 Colorant (rouge) 0,052 Exemple 2 Selon le mode opératoire de l'exemple 1 la composition nutritionnelle pour la nutrition des articulations chez les chiens a été préparée selon la présente invention.Brief Description of the Drawings 1: Results of palatability test of sweetened solidified gel in horses (n = 109) 2: Results of the palatability test of the unsweetened solidified gel in dogs of different breeds (n = 25) Examples of the invention Example 1 The example illustrates the optimal composition of 1 kg of the nutritional composition according to the invention for the joint nutrition in horses. The components in question are weighed and dissolved to be gradually mixed. The gelatin composition prepared as a solution is then poured into molds to allow it to solidify, then it is cut out and packaged in zipper bags. Component Quantity (g / kg) Pork gelatin (at least 200 Bloom) 130.448 Citrate buffer, molarity 50 mM; pH 5.8 400 Sucrose 292.5 Glucose syrup 43 DE 140 Potassium sorbate 8 Glycerol 4 Sodium hyaluronate (Nutrihyl®) 4 Chondroitin sulphate 19 Flavoring agent (sour cherry) 2 Color (red) 0.052 Example 2 According to the procedure of Example 1 Nutritional composition for joint nutrition in dogs was prepared according to the present invention.
Composant Quantité (g/kg) Gélatine de porc (min.Component Quantity (g / kg) Pork gelatin (min.
200 Bloom) 250 Hydrolysat de gélatine 67 Tampon au citrate, molarité 50 mM ; pH 5,8 600 Sorbate de potassium 12 Glycérol 4 Hyaluronate de sodium (Nutrihyl®) 5 Sulfate de chondroïtine 20 Sulfate de glucosamine 20 Méthylsulfonylméthane 20 Aromatisant de jambon fumé 2 Exemple 3 Selon le mode opératoire de l'exemple 1 la composition nutritionnelle ne contenant pas de tampon acide a été préparée. pH d'eau a été ajusté avec de l'acide citrique, mais il est possible d'utiliser d'autres acides organiques et inorganiques appropriés utilisés dans l'industrie alimentaire (lactique, malique, phosphorique, etc.). Composant Quantité (g/kg) Gélatine de porc (min.200 Bloom) 250 Gelatin hydrolyzate 67 Citrate buffer, 50 mM molarity; pH 5.8 600 Potassium sorbate 12 Glycerol 4 Sodium hyaluronate (Nutrihyl®) 5 Chondroitin sulphate 20 Glucosamine sulphate 20 Methylsulfonylmethane 20 Smoked ham smoker 2 Example 3 According to the procedure of Example 1, the nutritional composition not containing no acid buffer was prepared. Water pH has been adjusted with citric acid, but it is possible to use other suitable organic and inorganic acids used in the food industry (lactic, malic, phosphoric, etc.). Component Quantity (g / kg) Pork gelatin (min.
200 Bloom) 130,448 Eau à pH 5,8 400 Saccharose 292,5 Sirop de glucose 43 DE 140 Sorbate de potassium 8 Glycérol 4 Hyaluronate de sodium (Nutrihyl®) 4 Sulfate de chondroïtine 19 Aromatisant (griotte) 2 Colorant (rouge) 0,05215 Exemple 4 Selon le mode opératoire de l'exemple 2 la composition nutritionnelle ne contenant pas de tampon acide a été préparée selon la présente invention. pH d'eau a été ajusté avec de l'acide citrique, mais il est possible d'utiliser aussi d'autres acides organiques et inorganiques appropriés utilisés dans l'industrie alimentaire (lactique, malique, phosphorique, etc.). Composant Quantité (g/kg) Gélatine de porc (min.200 Bloom) 130,448 Water at pH 5.8 400 Sucrose 292.5 Glucose syrup 43 DE 140 Potassium sorbate 8 Glycerol 4 Sodium hyaluronate (Nutrihyl®) 4 Chondroitin sulphate 19 Flavoring (sour cherry) 2 Color (red) 0, EXAMPLE 4 According to the procedure of Example 2, the nutritional composition containing no acidic buffer was prepared according to the present invention. pH of water has been adjusted with citric acid, but it is possible to use also other suitable organic and inorganic acids used in the food industry (lactic, malic, phosphoric, etc.). Component Quantity (g / kg) Pork gelatin (min.
200 Bloom) 250 Hydrolysat de gélatine 67 Eau à pH 5,8 600 Sorbate de potassium 12 Glycérol 4 Hyaluronate de sodium (Nutrihyl®) 5 Le sulfate de chondroïtine 20 Le sulfate de glucosamine 20 Méthylsulfonylméthane 20 Aromatisant de jambon fumé 2200 Bloom) 250 Gelatin Hydrolyzate 67 Water pH 5.8 600 Potassium Sorbate 12 Glycerol 4 Sodium Hyaluronate (Nutrihyl®) 5 Chondroitin Sulfate 20 Glucosamine Sulfate 20 Methylsulfonylmethane 20 Smoked Ham Flavoring 2
Claims (15)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ2014-29122U CZ26523U1 (en) | 2014-01-23 | 2014-01-23 | Nutrient composition based on hyaluronate for joint nutrition |
Publications (1)
Publication Number | Publication Date |
---|---|
FR3016520A3 true FR3016520A3 (en) | 2015-07-24 |
Family
ID=50180576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1550479A Pending FR3016520A3 (en) | 2014-01-23 | 2015-01-21 | NUTRITIONAL COMPOSITION BASED ON HYALURONIC ACID FOR THE NUTRITION OF JOINTS |
Country Status (5)
Country | Link |
---|---|
AT (1) | AT14428U1 (en) |
CZ (1) | CZ26523U1 (en) |
DE (1) | DE202015100233U1 (en) |
DK (1) | DK201500011U3 (en) |
FR (1) | FR3016520A3 (en) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6476005B1 (en) * | 1998-03-24 | 2002-11-05 | George D. Petito | Oral and injectable nutritional composition |
US6391864B1 (en) | 1998-08-19 | 2002-05-21 | Joint Juice, Inc. | Food supplement containing a cartilage supplement |
WO2001001992A1 (en) | 1999-07-02 | 2001-01-11 | Sca Lohnherstellungs Ag | A solid formulation of glucosamine sulphate |
US6924273B2 (en) * | 2000-10-03 | 2005-08-02 | Scott W. Pierce | Chondroprotective/restorative compositions and methods of use thereof |
US6607745B2 (en) | 2001-05-18 | 2003-08-19 | Harry Leneau | Ingestion of hyaluronic acid for improved joint function and health |
US20030138543A1 (en) * | 2002-01-03 | 2003-07-24 | Bradley T. Baumann | Food product supplemented with proteoglycan precursors |
DE10217808A1 (en) | 2002-04-22 | 2003-11-13 | Gerhard Knapp | Food supplement combatting cartilage degradation in joints contains e.g. gelatine hydrolysate, water, vitamins, potassium sorbate, sodium benzoate and/or mandarin extract |
ES2281265B1 (en) * | 2005-11-24 | 2008-08-16 | Bioiberica, S.A. | COMPOSITIONS FOR THE TREATMENT OF ARTROSIS. |
US20110117207A1 (en) * | 2009-11-17 | 2011-05-19 | U.S. Nutraceuticals, LLC d/b/a Valensa International State of Incorporation: | Use of eggshell membrane formulations to alleviate joint pain |
-
2014
- 2014-01-23 CZ CZ2014-29122U patent/CZ26523U1/en not_active IP Right Cessation
-
2015
- 2015-01-20 DE DE201520100233 patent/DE202015100233U1/en not_active Expired - Lifetime
- 2015-01-20 AT ATGM50005/2015U patent/AT14428U1/en not_active IP Right Cessation
- 2015-01-21 FR FR1550479A patent/FR3016520A3/en active Pending
- 2015-01-22 DK DK201500011U patent/DK201500011U3/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AT14428U1 (en) | 2015-11-15 |
DK201500011U3 (en) | 2015-05-03 |
CZ26523U1 (en) | 2014-02-24 |
DE202015100233U1 (en) | 2015-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR3042713B1 (en) | EFFICIENT ANTIOXIDANT COMPOSITION FROM A SYNERGISTIC VIEWPOINT FOR PETS | |
JP4652486B2 (en) | Formulation for oral administration containing chondroitin sulfate-containing cartilage aqueous solvent extract and quercetin glycoside | |
US20050255147A1 (en) | Composition for dietary enrichment | |
FR2946882A1 (en) | GELIFIED VETERINARY SUSPENSION OF IRON | |
FR2558344A1 (en) | ADDITIVE FOR ANIMAL FEEDING IN THE FORM OF COMPOSITION | |
FR2510875A1 (en) | FEEDING FOOD AND ADDITIVES AND METHOD OF MAKING THE SAME | |
EP1902631A2 (en) | Plant-based natural antioxidant additive intended for animal nutrition | |
JP6414443B2 (en) | Nanoparticles based on components derived from natural products | |
JP5436895B2 (en) | Oral formulation containing water-extracted chondroitin and milk flavor | |
FR3016520A3 (en) | NUTRITIONAL COMPOSITION BASED ON HYALURONIC ACID FOR THE NUTRITION OF JOINTS | |
EP1135110B1 (en) | Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses | |
FR2720944A1 (en) | Therapeutic or dietary composition in the form of a medicated gel for administration to pets. | |
CA2909750C (en) | Liquid or semi-liquid pharmaceutical, dietary or food composition free of bitterness containing an arginine salt | |
JP7040898B2 (en) | Oral composition for promoting type III collagen production containing a hydrolyzed eggshell membrane component as an active ingredient | |
FR2969905A1 (en) | Composition, useful for the nutrition of farm animals, as dietary supplement, and for preventing premature aging and protecting cells against damage caused by free radicals in farm animals, comprises aerial parts of nettle and apple pomace | |
JP7167288B2 (en) | Compression molded formulation | |
ES2973453T3 (en) | Palatable composition comprising hydrolyzed alpha-s1-casein | |
FR3030277A1 (en) | ||
JP2016124804A (en) | Production method of nanoparticles containing naturally occurring component as substrate | |
FR3123542A1 (en) | NEW FLUIDIFIED COMPOSITION CONTAINING ROYAL JELLY | |
JP6476697B2 (en) | Nanoparticles containing gelatin | |
FR2936952A1 (en) | Product, useful as nutritional supplements, comprises a composition in powder/anhydrous liquid form, having active ingredient and gelling agent e.g. lecithin and alginic acid, where composition is enclosed in edible water-soluble envelope | |
WO2014136036A1 (en) | Nutritional and medicinal oral composition for veterinary use | |
FR2987560A3 (en) | MINERAL MATRIX FOR SOLID FORMS OF PREPARATION FOR THE ADMINISTRATION OF NUTRIENT AND / OR PHARMACOLOGICAL SUBSTANCES, USE OF SAID MATRIX AND PROCESS FOR MAKING SAME | |
FR2796843A1 (en) | CONCENTRATED AND STABILIZED ANTIPYRETIC COMPOSITION FOR VETERINARY USE INTENDED TO BE INCORPORATED IN ANIMAL FEEDING AS WELL AS A METHOD OF INCORPORATING THIS COMPOSITION INTO ANIMAL BEVERAGE WATER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |